483 Document: Sarepta Therapeutics, Inc., Apr 12, 2018

FDANews 483 Sarepta Therapeutics, Inc. Apr 12 2018 top
Kent A. Conforti FDA Investigator

On Apr 12, 2018, the FDA inspected Sarepta Therapeutics, Inc.'s Cambridge site. Explore the inspectional observations.